Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease.

Bai D. L., Tang X. C., He X. C.
Current Medicinal Chemistry, 2000

Abstract

HupA is a potent, reversible and selective inhibitor of AChE with a rapid absorption and penetration into the brain in animal tests. It exhibits memory-enhancing activities in animal and clinical trials. Compared to tacrine and donepezil, HupA possesses a longer duration of action and higher therapeutic index, and the peripheral cholinergic side effects are minimal at therapeutic doses. This review article deals with a comprehensive survey of the progress in chemical and pharmacological studies of HupA including the isolation and structure elucidation, pharmacological actions, total synthesis, SAR studies and the future development of HupA. Recently, it has been reported that HupA could reduce neuronal cell death caused by glutamate. The dual bio-activities of HupA would further enhance its value and potentiality as the therapeutic agent for Alzheimer s disease.

PMID:10637369
Category:Brain / Mental Clarity

The best supplements with Selagine in Brain / Mental Clarity category:

  • NooCube - NooCube is a synergistic blend of nootropics which helps support and enhance your focus, mental speed and memory. It contains among others: Selagine.
  • Brain Pill - „An amazing new product that supports your brain health and has the potential to change your life returning laser-sharp mental clarity” - Dr Dave David, a surgeon and physician for more than 37 years. It contains among others: Selagine.
  • Pure Nootropics Huperzine A Capsules - Huperzine A is an alkaloid chemical compound extracted from the Chinese herb Huperzia serrata. It contains among others: Selagine.

Articles similar to "Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease."

Previous article

Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases.

Next article

An update on huperzine A as a treatment for Alzheimer's disease.